Feeds
6810 items (6810 unread) in 74 feeds
Acinar Cell Carcinoma
(81 unread)
Acinic Cell Carcinoma
(46 unread)
Adenoid Cystic Carcinoma
(159 unread)
Adrenal Gland Cancer
(533 unread)
Ampulla Of Vater
(68 unread)
Anal Cancer
(425 unread)
Angiosarcoma
(153 unread)
Appendix Cancer
(104 unread)
Bile Duct Cancer
(845 unread)
Brain and CNS
(878 unread)
Carcinoid
(266 unread)
Endocrine/Neuroendocrine
(808 unread)
Gall Bladder Cancer
(381 unread)
Hemangioendothelioma
(215 unread)
Hepatoblastoma
(129 unread)
Pancreas
(117 unread)
Phyllodes
(105 unread)
PMP and Mucinous Tumors
(114 unread)
Rhabdomyosarcoma
(246 unread)
Sarcoma
(1137 unread)
Google - Rare CNS Tumor (100 unread)
-
Latest Analyses of Vitrakvi® (larotrectinib) Support Consistently Meaningful Clinical Profile for Both Adult and Pediatric Patients with TRK Fusion Cancer - Business Wire
Posted: September 16th, 2021, 4:30am GMT
-
Vinblastine monotherapy induction prior to radiotherapy for patients with intracranial germinoma during the COVID‐19 pandemic - Wiley
Posted: September 14th, 2021, 9:58pm GMT
-
How to Identify the Real Cause of Your Anxiety - PsychCentral.com
Posted: September 14th, 2021, 7:53pm GMT
How to Identify the Real Cause of Your Anxiety PsychCentral.com -
Healthcare survey reveals lag in child cancer diagnosis - Telegraph India
Posted: September 14th, 2021, 7:12pm GMT
Healthcare survey reveals lag in child cancer diagnosis Telegraph India -
Robert Lober, MD, PhD, leads brain cancer research at Dayton Children's Hospital - Dayton Business Journal - Dayton Business Journal
Posted: September 14th, 2021, 6:38pm GMT
-
Meal Train Volunteers Needed for Cancer Patient, Jacob Ferch - Racine County Eye
Posted: September 14th, 2021, 2:53pm GMT
Meal Train Volunteers Needed for Cancer Patient, Jacob Ferch Racine County Eye -
Meal Train Volunteers Needed for Cancer Patient, Jacob Ferch - Racine County Eye
Posted: September 14th, 2021, 2:53pm GMT
Meal Train Volunteers Needed for Cancer Patient, Jacob Ferch Racine County Eye -
AB Science announced today that results from masitinib study AB12003 in prostate cancer have been presented - GlobeNewswire
Posted: September 13th, 2021, 2:04pm GMT
-
FDA Action Alert: Calliditas, Merck and BeiGene - BioSpace
Posted: September 13th, 2021, 11:11am GMT
-
Hemangioblastoma: Signs, Symptoms, and Complications - Verywell Health
Posted: September 13th, 2021, 5:00am GMT
Hemangioblastoma: Signs, Symptoms, and Complications Verywell Health -
'Malignant' twist ending explained: Medical fact or fiction - Los Angeles Times
Posted: September 10th, 2021, 9:53pm GMT
'Malignant' twist ending explained: Medical fact or fiction Los Angeles Times -
Childhood Cancer Awareness Month - Walterboro Live
Posted: September 10th, 2021, 7:00am GMT
Childhood Cancer Awareness Month Walterboro Live -
Seizure disorder: Types, causes, and more - Medical News Today
Posted: September 10th, 2021, 6:53am GMT
Seizure disorder: Types, causes, and more Medical News Today -
'Childhood Alzheimer's': Causes, symptoms, and more - Medical News Today
Posted: September 10th, 2021, 6:53am GMT
'Childhood Alzheimer's': Causes, symptoms, and more Medical News Today -
Takotsubo Syndrome: Optimizing Care with a Multidisciplinary Approach | JMDH - Dove Medical Press
Posted: September 10th, 2021, 6:30am GMT
Takotsubo Syndrome: Optimizing Care with a Multidisciplinary Approach | JMDH Dove Medical Press -
Cancer risk in adolescents and young adults living with HIV in South Africa: a nationwide cohort study - The Lancet
Posted: September 9th, 2021, 8:32pm GMT
-
Investors Pour $360 Million into Cutting-Edge Biotechs - BioSpace
Posted: September 9th, 2021, 2:35pm GMT
-
Mobocertinib Elicits Efficacy in Advanced EGFR Exon 20 Insertion+ NSCLC Regardless of Prior Immunotherapy - OncLive
Posted: September 9th, 2021, 1:42pm GMT
-
Bayer to Highlight Expanded Research from Growing Oncology Portfolio at ESMO Congress 2021 - Business Wire
Posted: September 9th, 2021, 10:00am GMT
-
Central Nervous System Lymphoma Pipeline Market Clinical Studies, NDA Approvals, Key Companies, Future Perspectives and Conclusion - Digital Journal
Posted: September 9th, 2021, 5:10am GMT
-
Eli Lilly bets on an RNA base editing outfit leveraging the body's own enzymes to reverse mutations - Endpoints News
Posted: September 8th, 2021, 6:01pm GMT
-
Plus Therapeutics to Present at the HC Wainwright Global - Health Bollyinside - BollyInside
Posted: September 8th, 2021, 3:35pm GMT
-
Mediastinal small cell carcinoma & cutaneous cryptococcosis | IDR - Dove Medical Press
Posted: September 8th, 2021, 11:52am GMT
Mediastinal small cell carcinoma & cutaneous cryptococcosis | IDR Dove Medical Press -
Diagnosis and Treatment of Three Primary Malignant Tumors | BCTT - Dove Medical Press
Posted: September 8th, 2021, 11:39am GMT
Diagnosis and Treatment of Three Primary Malignant Tumors | BCTT Dove Medical Press -
Plus Therapeutics to Present at the H.C. Wainwright Global Investment Conference - Stockhouse
Posted: September 8th, 2021, 9:09am GMT
-
Plus Therapeutics to Present at the H.C. Wainwright Global Investment Conference - Yahoo Finance
Posted: September 8th, 2021, 9:00am GMT
-
Vect-Horus and MDimune Collaborate to Develop a Novel Approach to CNS Drug Delivery Based on Vectorized Cell-derived Vesicles (CDVs) - BioSpace
Posted: September 7th, 2021, 3:33pm GMT
-
Vect-Horus and MDimune Collaborate to Develop a Novel Approach to CNS Drug Delivery Based on Cell-derived - EIN News
Posted: September 6th, 2021, 4:36am GMT
-
Centene, ACADIA: Why These Out Of Favor Health Care Stocks Are Worth A Look - Nasdaq
Posted: September 6th, 2021, 3:02am GMT
-
Roundtable Discussion: Antonoff Discusses Treatment Goals in NSCLC - Targeted Oncology
Posted: September 4th, 2021, 1:00pm GMT
Roundtable Discussion: Antonoff Discusses Treatment Goals in NSCLC Targeted Oncology -
News from Sierra Nevada Memorial Hospital and Hospital Foundation - The Union of Grass Valley
Posted: September 3rd, 2021, 4:27pm GMT
News from Sierra Nevada Memorial Hospital and Hospital Foundation The Union of Grass Valley -
Kinder and more effective - why childhood cancers need specific treatments - Cancer Research UK
Posted: September 3rd, 2021, 10:29am GMT
Kinder and more effective - why childhood cancers need specific treatments Cancer Research UK -
Plus Therapeutics, Inc. Announces Commercial Manufacturing Supply Agreement for Its Lead Investigational Drug with RadioMedix, Inc - marketscreener.com
Posted: September 3rd, 2021, 10:29am GMT
-
Centene, ACADIA: Why These Out Of Favor Health Care Stocks Are Worth A Look - Forbes
Posted: September 3rd, 2021, 10:00am GMT
-
Research For Life awards $82,745 to Wellington Researchers | Scoop News - Scoop.co.nz
Posted: September 2nd, 2021, 7:27pm GMT
-
Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis: Pathophysiology, Diagnosis, and the Evolving Treatment Landscape - AJMC.com Managed Markets Network
Posted: September 2nd, 2021, 2:09pm GMT
Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis: Pathophysiology, Diagnosis, and the Evolving Treatment Landscape AJMC.com Managed Markets Network -
Centene, ACADIA: Why These Out Of Favor Health Care Stocks Are Worth A Look - Trefis
Posted: September 2nd, 2021, 12:00pm GMT
-
San Antonio nonprofit bringing joy to pediatric cancer patients through ‘smile packs’ - KSAT San Antonio
Posted: September 2nd, 2021, 11:49am GMT
-
The McQuade Center for Strategic Research and Development Enters Agreement with Sentinel Oncology to Develop Breakthrough Treatment for Fragile X Syndrome - The Bakersfield Californian
Posted: September 2nd, 2021, 11:01am GMT
-
The McQuade Center for Strategic Research and Development Enters Agreement with Sentinel Oncology to Develop Breakthrough Treatment for Fragile X Syndrome - Yahoo Finance
Posted: September 2nd, 2021, 11:00am GMT
-
The McQuade Center for Strategic Research and Development Enters Agreement with Sentinel Oncology to Develop Breakthrough Treatment for Fragile X Syndrome - Business Wire
Posted: September 2nd, 2021, 11:00am GMT
-
Propranolol in the Treatment of Infantile Hemangiomas | CCID - Dove Medical Press
Posted: September 2nd, 2021, 10:22am GMT
Propranolol in the Treatment of Infantile Hemangiomas | CCID Dove Medical Press -
Plus Therapeutics Announces Commercial Manufacturing Supply Agreement for Its Lead Investigational Drug - BioSpace
Posted: September 2nd, 2021, 9:20am GMT
-
Plus Therapeutics Announces Commercial Manufacturing Supply Agreement for Its Lead Investigational Drug - Stockhouse
Posted: September 2nd, 2021, 9:08am GMT
-
Plus Therapeutics Announces Commercial Manufacturing Supply Agreement for Its Lead Investigational Drug - Yahoo Finance
Posted: September 2nd, 2021, 9:00am GMT
-
On the watch for pediatric cancers - Medical Xpress
Posted: September 1st, 2021, 6:34pm GMT
On the watch for pediatric cancers Medical Xpress -
The Medical Minute: On the watch for pediatric cancers | Penn State University - Penn State News
Posted: September 1st, 2021, 4:33pm GMT
-
Primary Central Nervous System Vasculitis: From Diagnosis to Management - Neurology Advisor
Posted: September 1st, 2021, 1:30pm GMT
Primary Central Nervous System Vasculitis: From Diagnosis to Management Neurology Advisor -
An Unusual Pigmented Plaque in a Newborn | American Academy of Pediatrics - AAP News
Posted: September 1st, 2021, 9:12am GMT
-
Hot off of a $210 million Series B, Umoja breaks ground in Colorado on CAR-T site - Endpoints News
Posted: September 1st, 2021, 5:00am GMT
-
As bankruptcy neared, workers at a USAntibiotics site worked until the lights went out. Now, the site will get a second life - Endpoints News
Posted: September 1st, 2021, 5:00am GMT
-
Covid-19 manufacturing roundup: Stainless steel identified as foreign item in Japanese Moderna lots; DoD contract enables pipette manufacturing - Endpoints News
Posted: September 1st, 2021, 5:00am GMT
-
Von Hippel-Lindau Disease Therapeutic Market Size Expected to Surge at a CAGR of 8.3% for the Study Period 2018-2030 | DelveInsight - Yahoo Finance
Posted: August 31st, 2021, 3:30pm GMT
-
Von Hippel-Lindau Disease Therapeutic Market Size Expected to Surge at a CAGR of 8.3% for the Study Period 2018-2030 | DelveInsight - PRNewswire
Posted: August 31st, 2021, 3:30pm GMT
-
FDA grants orphan drug designation to LP-184 for glioblastoma multiforme - Healio
Posted: August 30th, 2021, 1:30pm GMT
-
FDA Grants Lantern Pharma Additional Orphan Drug Designation for Drug Candidate LP-184 in Glioblastoma Multiforme & Malignant Gliomas - PRNewswire
Posted: August 30th, 2021, 10:59am GMT
-
Waldenström's macroglobulinemia - JBM | JBM - Dove Medical Press
Posted: August 30th, 2021, 9:41am GMT
Waldenström's macroglobulinemia - JBM | JBM Dove Medical Press -
Acute myeloid leukemia and COVID-19: A guide - Medical News Today
Posted: August 30th, 2021, 5:00am GMT
Acute myeloid leukemia and COVID-19: A guide Medical News Today -
Editas: Gene Therapy Specialist Leading The Way In Eye Disease - Seeking Alpha
Posted: August 27th, 2021, 7:09pm GMT
-
What Is a Possible Cause for My Loss of Smell and Taste? COVID-19 - MedicineNet
Posted: August 27th, 2021, 1:54am GMT
-
Potential Translational Relevance of Preclinical Findings With Seribantumab - Cancer Network
Posted: August 27th, 2021, 12:03am GMT
-
Amid questions about cost and access, proton therapy set for 'big moment of change' - Healio
Posted: August 25th, 2021, 2:52pm GMT
-
Does proton therapy have a role in the treatment of brain tumors? - Healio
Posted: August 25th, 2021, 2:50pm GMT
-
Osimertinib in EGFR-mutated lung cancer | OTT - Dove Medical Press
Posted: August 25th, 2021, 11:50am GMT
Osimertinib in EGFR-mutated lung cancer | OTT Dove Medical Press -
Report shows adult brain tumor incidence rates are decreasing but 5-year survival rates remain low: Data show a slight increase in brain tumors among children and adolescents - Science Daily
Posted: August 24th, 2021, 9:00pm GMT
-
Vomiting: Causes, medication, treatment, and more - Medical News Today
Posted: August 24th, 2021, 3:15pm GMT
Vomiting: Causes, medication, treatment, and more Medical News Today -
Clinicopathologic and Genomic Testing Confirm Differences in Pediatric Melanocytic Tumors - OncLive
Posted: August 24th, 2021, 3:02pm GMT
-
Global Liver Cancer Therapeutics Market Size Is Forecasted To Grow To $1.148 Billion By 2026 - PRNewswire
Posted: August 24th, 2021, 10:45am GMT
-
Global Liver Cancer Therapeutics Market Size Is Forecasted To Grow To $1.148 Billion By 2026 - PR Newswire UK
Posted: August 24th, 2021, 10:45am GMT
-
Report reveals adult brain tumor incidence rates are decreasing but 5-year survival rates remain low - Mirage News
Posted: August 24th, 2021, 8:02am GMT
-
Rates of Brain Tumors in Adults Are Decreasing, but Survival Remains Low - Cancer Health Treatment News
Posted: August 24th, 2021, 5:00am GMT
Rates of Brain Tumors in Adults Are Decreasing, but Survival Remains Low Cancer Health Treatment News -
Reactive Langerhans cell proliferation | CCID - Dove Medical Press
Posted: August 24th, 2021, 4:53am GMT
Reactive Langerhans cell proliferation | CCID Dove Medical Press -
Treatment With FHD-609 Begins in Phase 1 Synovial Sarcoma Study - Targeted Oncology
Posted: August 23rd, 2021, 4:28pm GMT
Treatment With FHD-609 Begins in Phase 1 Synovial Sarcoma Study Targeted Oncology -
Benefits Of Taking Low Dose Naltrexone — Hometown Station | KHTS FM 98.1 & AM 1220 — Santa Clarita Radio - Santa Clarita News - KHTS Radio
Posted: August 23rd, 2021, 1:50pm GMT
-
Future of Care for PCNSL Relies on Adapting Personalized Approaches - OncLive
Posted: August 23rd, 2021, 12:46pm GMT
-
Korea, Taiwan lead growth of regenerative medicine in Asia-Pacific region - Korea Biomedical Review
Posted: August 23rd, 2021, 7:39am GMT
Korea, Taiwan lead growth of regenerative medicine in Asia-Pacific region Korea Biomedical Review -
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological sp... - Physician's Weekly
Posted: August 23rd, 2021, 3:32am GMT
-
Analysis Offers Longer-Term Safety Profile of CAR T-Cell Therapy for B-ALL - AJMC.com Managed Markets Network
Posted: August 22nd, 2021, 3:15pm GMT
Analysis Offers Longer-Term Safety Profile of CAR T-Cell Therapy for B-ALL AJMC.com Managed Markets Network -
Four biotech startup reel in $238M in financing to ramp up for clinical trials - MedCity News
Posted: August 22nd, 2021, 10:03am GMT
-
The NGS based CDx Human NTRK1/2/3 Genomic Alteration Test Kit to inform treatment decisions for larotrectinib developed by OrigiMed in cooperation with Bayer was granted the NMPA Special Review Proced - StreetInsider.com
Posted: August 22nd, 2021, 11:07pm GMT
-
The NGS based CDx Human NTRK1/2/3 Genomic Alteration Test Kit to inform treatment decisions for larotrectinib developed by OrigiMed in cooperation with Bayer was granted the NMPA Special Review Procedure for Innovative Medical Devices in China - Maryvill
Posted: August 22nd, 2021, 11:00pm GMT
-
The NGS based CDx Human NTRK1/2/3 Genomic Alteration Test Kit to inform treatment decisions for larotrectinib developed by OrigiMed in cooperation with Bayer was granted the NMPA Special Review Procedure for Innovative Medical Devices in China - The Bake
Posted: August 22nd, 2021, 11:00pm GMT
-
Plus Therapeutics Announces Presentation of Data from the - Health Bollyinside - BollyInside
Posted: August 21st, 2021, 1:09pm GMT
-
Plus Therapeutics Announces Presentation of Data from the ReSPECT(TM)-GBM Trial and Plans for Treating Pediatric Brain Cancer - Stockhouse
Posted: August 21st, 2021, 12:01pm GMT
-
Plus Therapeutics Announces Presentation of Data from the ReSPECT™-GBM Trial and Plans for Treating Pediatric Brain Cancer - StreetInsider.com
Posted: August 21st, 2021, 11:25am GMT
-
Plus Therapeutics Announces Presentation of Data from the ReSPECT - GlobeNewswire
Posted: August 21st, 2021, 11:24am GMT
-
Plus Therapeutics Announces Presentation of Data from the ReSPECT™-GBM Trial and Plans for Treating Pediatric Brain Cancer - BioSpace
Posted: August 21st, 2021, 11:18am GMT
-
FDA Updates: Opdivo, Jardiance and Jemperli Get Nods for New Indications - Managed Healthcare Executive
Posted: August 21st, 2021, 11:05am GMT
FDA Updates: Opdivo, Jardiance and Jemperli Get Nods for New Indications Managed Healthcare Executive -
Plus Therapeutics Announces Presentation of Data from the ReSPECT™-GBM Trial and Plans for Treating Pedia - Benzinga
Posted: August 21st, 2021, 5:00am GMT
-
Management of Primary CNS lymphoplasmacytic lymphoma | JBM - Dove Medical Press
Posted: August 21st, 2021, 12:46am GMT
Management of Primary CNS lymphoplasmacytic lymphoma | JBM Dove Medical Press -
FDA Drug Approvals, Pediatrics — 2021 Midyear Review - Medscape
Posted: August 20th, 2021, 6:27pm GMT
-
Community Rallying For Beloved Morris School Teacher After Teen Son Diagnosed With Rare Cancer - Rutherford Daily Voice
Posted: August 20th, 2021, 4:26pm GMT
-
Morris Preschool Teacher Copes With Teen Son's Cancer Diagnosis - Patch.com
Posted: August 20th, 2021, 5:00am GMT
-
Plus Therapeutics : Announces Presentation of Data from the ReSPECT™-GBM Trial and Plans for Treating Pediatric Brain Cancer - marketscreener.com
Posted: August 20th, 2021, 5:00am GMT
-
Extranodal NK/T-cell Lymphoma Primarily in the Eyes | CMAR - Dove Medical Press
Posted: August 19th, 2021, 1:30pm GMT
Extranodal NK/T-cell Lymphoma Primarily in the Eyes | CMAR Dove Medical Press -
What to trust, PSA or [68Ga]PSMA-11: learn from experience | RRU - Dove Medical Press
Posted: August 19th, 2021, 12:15pm GMT
What to trust, PSA or [68Ga]PSMA-11: learn from experience | RRU Dove Medical Press -
Characteristics of adult hemophagocytic lymphohistiocytosis | IJGM - Dove Medical Press
Posted: August 19th, 2021, 11:12am GMT
Characteristics of adult hemophagocytic lymphohistiocytosis | IJGM Dove Medical Press -
Onco360® Selected by Merck & Co., Inc. to Be in Specialty Pharmacy Network for WELIREG™ (belzutifan) - Argus Press
Posted: August 19th, 2021, 11:02am GMT
-
Onco360® Selected by Merck & Co., Inc. to Be in Specialty Pharmacy Network for WELIREG™ (belzutifan) - The Bakersfield Californian
Posted: August 19th, 2021, 11:02am GMT
Onco360® Selected by Merck & Co., Inc. to Be in Specialty Pharmacy Network for WELIREG™ (belzutifan) The Bakersfield Californian -
Lantern Pharma Announces Positive Preclinical Data in Glioblastoma (GBM) with Drug Candidate LP-184 and Expands GBM Research Collaboration - Markets Insider
Posted: August 19th, 2021, 11:00am GMT